Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients
Open Access
- 31 December 2004
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 10 (12), 858-866
- https://doi.org/10.1016/j.bbmt.2004.09.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Expression of TNFα by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantationBone Marrow Transplantation, 2003
- Donor T cell–derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantationBlood, 2003
- Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200Blood, 2003
- Nonmyeloablative allogeneic stem cell transplantation for the treatment of chronic myeloid leukemia in first chronic phaseBlood, 2003
- High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantationBone Marrow Transplantation, 2002
- Allogeneic bone marrow transplant or second autograft in patients with acute leukemia who relapse after an autograftBone Marrow Transplantation, 1999
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Granulocyte-Colony Stimulating Factor (G-CSF)-Primed, Delayed Marrow Harvests as a Source of Hematopoietic Stem and Progenitor Cells for Allogeneic TransplantationLeukemia & Lymphoma, 1999
- TREATMENT OF RENAL ALLOGRAFT REJECTION WITH T10B9.1A31 OR OKT3Transplantation, 1997
- Rapid Communication: Increased Frequency of TCRγδ+ T Cells in Disease-Free Survivors Following T Cell-Depleted, Partially Mismatched, Related Donor Bone Marrow Transplantation for LeukemiaPublished by Mary Ann Liebert Inc ,1996